In a recent STAT article Sanofi CEO Paul Hudson discusses the potential of artificial intelligence (AI) in the pharmaceutical industry. While some in the industry have been hesitant to embrace…
The post From Expert AI to Snackable AI: A New Era in Phar…
From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO Read Post »
In the world of patents, the right to exclude others from using or selling an invention is granted only during the patent’s validity. Once a patent expires, this exclusivity vanishes.…
The post Understanding Patent Term Extensions: An Overview appeared…
Understanding Patent Term Extensions: An Overview Read Post »
Pharmacists play a crucial role in drug repurposing due to the vast amount of opportunities that exist in this innovative approach. Drug development and registration can be costly, time-consuming, and…
The post Pharmacists Can Play Key Role in Drug Rep…
Pharmacists Can Play Key Role in Drug Repurposing Read Post »
In a guest column Kevin Wall, principal consultant and owner of Cincero Consulting, emphasizes the critical importance of selecting the right Contract Development and Manufacturing Organization (CDMO) for drug product…
The post Key Factors for Choosing…
Loss of exclusivity (LOE) doesn’t have to spell doom for branded drug revenue streams. In the face of impending patent expirations, pharmaceutical companies can adopt key approaches to preserve meaningful…
The post Strategies to Maximize Product Value …
A recent paper in Expert Opinion on Biological Therapy studies failed fillings for biosimilar drugs. Over the past three decades, biotherapeutics have revolutionized healthcare by providing effective treatments for complex diseases…
The post Unsuccessf…
Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review Read Post »
DrugPatentWatch now offers single drug reports for purchase on Amazon. These reports provide valuable insights and information about specific drugs. This convenient availability on Amazon allows users to easily access…
The post Drug Patent Reports now …
A recent paper published in the journal “Intelligent Medicine” article discusses various aspects of using AI and machine learning in the pharmaceutical industry for drug discovery and development. Results The…
The post Artificial Intelligence and Machi…
Artificial Intelligence and Machine Learning in Drug Discovery and Development Read Post »
A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding. The article sheds…
The post Prevalence and timing of au…
Prevalence and timing of authorized generics in the US market Read Post »
A recent update from Foley & Lardner attorney Courtenay C. Brinckerhoff discusses trends in Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings involving Orange Book and biologic patents, based…
The post Insights into Shifting Dynamics: O…
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends Read Post »